Featured Commentary


Markets / Commentaries

Consumer Confidence Slides In July

Harvey S. Katz | 07/28/2015

Just when it looked as though most of the stars were aligned for the economic bulls, comes word that consumer confidence, one of the major indicators of economic health, came in well below expectations in July. That finding was according to a release made earlier this morning by The Conference Board, a private research group.

Read more
Stocks / Highlights
Dow 30 Earnings: Merck Second Quarter 2015

Michael Ratty | 07/28/2015

Merck a New Jersey-based drugmaker and Dow-30 component, has reported second-quarter adjusted earnings of $0.86 a share, versus $0.85 in the comparable period of 2014. The bottom-line tally came in ahead of our $0.80 estimate thanks to better-than-expected sales growth in diabetes and cancer drugs, partially offset by a negative impact from the stronger dollar.

Read more
Stocks / Highlights
Dow 30 Earnings: Pfizer Second Quarter 2015

Michael Ratty | 07/28/2015

Strong gains in the PREVNAR vaccine franchise and better sales of the new breast cancer drug IBRANCE helped Pfizer’s (PFE) second-quarter results to top expectations.

Read more
Stocks / Highlights
Dow 30 Earnings: DuPont Second Quarter 2015

Michael Napoli | 07/28/2015

Diversified chemicals manufacturer and Dow-30 component DuPont delivered weaker-than-expected second-quarter results. Although operating margins improved in five of the company's six operating segments, driven by increased productivity, a stronger U.S. dollar hurt performance across the board.

Read more
Stocks / Commentaries
Dogs of the Dow Midyear Review

Mario Ferro | 07/27/2015

Although the year has been notable for the major indexes hitting new all-time nominal highs, stocks have had a tough time staying in positive territory. Among the factors making up this year’s “wall of worry” have been low oil prices, debt woes in Greece, and the Federal Reserve’s imminent first step toward monetary tightening. As it pertains to the Dow Jones Industrial Averages, a 2.5% dip in June landed the index 1.3 percentage points in the red for the year to date. Meanwhile, the Dogs of the Dow have largely underperformed, beating their benchmark index in only two out of six months in the first half. June marked a second-consecutive month of losses for the mutts. But, on the whole, they were not trailing by an exceedingly wide margin at the half.

Read more
Markets / Commentaries
New Home Sales Falter In June

Harvey S. Katz, CFA | 07/24/2015

New home sales fell to a seven-month low in June, in a surprise setback in a market that has been roaring ahead on most fronts. In all, such sales declined by 6.8%, to a seasonally adjusted annualized rate of 482,000 homes sold last month. Worse, May's sales pace was revised down from an estimated 546,000 homes sold annually, to just 517,000 properties.

Read more
Stocks / Highlights
Dow 30 Earnings: Visa Inc. Fiscal Third Quarter 2015

Sharif Abdou | 07/24/2015

Electronic payments processor Visa (V) has reported stellar results for the fiscal 2015 third quarter, and shares of the Dow-30 component moved notably higher in pre-market trading, as a result.

Read more
Stocks / Highlights
Dow 30 Earnings: 3M Company Second Quarter 2015

Andre Costanza | 07/23/2015

Diversified manufacturer and Dow-30 component 3M Company (MMM) posted disappointing second-quarter results, sending its stock down.

Read more
Stocks / Highlights
Dow 30 Earnings: Caterpillar Inc. Second Quarter 2015

Dominic Silva | 07/23/2015

 Caterpillar (CAT) shares were a bit lower in early trading, touching a new 52-week low, after the heavy equipment manufacturer and Dow-30 staple lowered guidance for this year.

Read more